Larimar Therapeutics

-$0.11 (-0.91%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LRMR and other ETFs, options, and stocks.

About LRMR

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia.

CEO
Carole S. Ben-Maimon
Employees
28
Headquarters
Bala Cynwyd, Pennsylvania
Founded
2005

LRMR Key Statistics

Market Cap
212.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
36.81K
High Today
$12.15
Low Today
$11.10
Open Price
$11.95
Volume
45.60K
52 Week High
$25.87
52 Week Low
$7.00

LRMR Earnings

-$1.21
-$0.81
-$0.40
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure